
USFDA APPLICATION NUMBER - 21227 / DOSAGE - POWDER;INTRAVENOUS - 50MG/VIAL
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength | 
|---|---|---|
| CASPOFUNGIN ACETATE(UNII: VUW370O5QE) (CASPOFUNGIN - UNII:F0XDI6ZL63)  | CASPOFUNGIN ACETATE | 5mg in 1 | 7mg in 1 | 
Inactive Ingredients
| Ingredient Name | Alvogen Inc.  | Athenex Pharmaceutical Division, LLC.  | Cipla USA Inc.  | Merck Sharp & Dohme LLC  | Mylan Institutional LLC  | 
					
|---|---|---|---|---|---|
| acetic acid(Q40Q9N063P) | |||||
| MANNITOL(3OWL53L36A) | |||||
| SODIUM HYDROXIDE(55X04QC32I) | |||||
| sucrose(C151H8M554) |